| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.57B | +1.6% | +278.1% |
| R&D Expense | $20.8M | +52.6% | +3.1% |
| SG&A Expense | $13.1M | -62.9% | -53.0% |
| Operating Income | -$9.1M | +55.4% | +64.3% |
| Pre-tax Income | -$5.9M | +68.6% | -103.0% |
| Income Tax | $343K | -6.5% | -92.6% |
| Net Income | -$2.1M | +64.8% | -101.1% |
| EPS (Basic) | -$0.07 | -250.0% | -112.7% |
| EPS (Diluted) | -$0.07 | -250.0% | -112.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $237.8M | -47.4% | -26.1% |
| Current Assets | $902.5M | -8.2% | +117.9% |
| Total Assets | $3.98B | -2.8% | +227.5% |
| Current Liabilities | $908.0M | -22.0% | +54.3% |
| Total Liabilities | $1.33B | -8.2% | +60.4% |
| Stockholders' Equity | $812.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$412.4M | -105.9% | -355.5% |
| Capital Expenditures | $599K | +15.2% | +72.1% |
| Investing Cash Flow | $261.7M | -1.0% | +7171.4% |
| Financing Cash Flow | $394.6M | +0.0% | — |
| Free Cash Flow | -$413.0M | -105.6% | -356.4% |
| +108.7% |